Related Experiment Video

Updated: Jul 6, 2025

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

14.9K

Recalcitrant lichen planus pigmentosus treated with topical ruxolitinib

Hannah L Cornman1, Elena Wei1, Jaya Manjunath1

  • 1Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

JAAD Case Reports
|December 29, 2023
PubMed
Abstract

No abstract available in PubMed .

Keywords:
JAK inhibitorcreamhyperpigmentationjanus kinase inhibitorlichen planus pigmentosusrecalcitrantruxolitinibtopical

More Related Videos

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.0K
Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
04:12

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid

Published on: January 19, 2024

922

Related Experiment Videos

Last Updated: Jul 6, 2025

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

14.9K
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.0K
Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
04:12

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid

Published on: January 19, 2024

922

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K

Articles linked to this work by shared authors, journal, and citation graph.

Cutaneous Adverse Effects of Hormonal and HER2-Targeted Therapies in Breast Cancer Patients: A Case Series.

Journal of drugs in dermatology : JDD·2026

Somatic mutations reveal hyperactive Notch signaling in prurigo nodularis.

JCI insight·2026

Therapeutic Approaches for Cutaneous Lupus Erythematosus: a Changing Landscape of Clinical Trials.

Journal of inflammation research·2026

Clustering analysis of circulating plasma-biomarkers in atopic dermatitis reveals a distinct-inflammatory cardiac risk profile in African American patients.

Research square·2025

Comorbidities in prurigo nodularis.

Clinics in dermatology·2025

Anti-nuclear matrix protein 2 antibody-positive dermatomyositis associated with smouldering myeloma mimicking anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: A case of digital gangrene, palmar papules, and scrotal rash.

Modern rheumatology case reports·2025

Unexpected viability in avascular necrosis of proximal pole of scaphoid with nonunion: a case of spontaneous revascularization.

Annals of medicine and surgery (2012)·2026

Conical Intersection-Mediated Nonradiative Decay in an ESIPT-Active Imidazole Derivative.

The journal of physical chemistry. A·2026

Granular parakeratosis associated with the use of laundry sanitizers containing benzalkonium chloride: a case report.

Frontiers in allergy·2026

Kinetic and Mechanistic Characterization of RSpFAST, a Non-Covalent Versatile Chemogenetic Platform for Fluorescence Imaging.

Journal of the American Chemical Society·2026

CPL inversion via switching between prompt fluorescence and afterglow phosphorescence in chiral Al(III) and In(III) complexes.

Chemical communications (Cambridge, England)·2026

pKa engineering of a near-infrared fluorescent probe for sensitive imaging of oxidative stress in atherosclerotic plaques.

Smart molecules : open access·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us